Antimicrobial combination therapy

This page covers all Antimicrobial combination therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Helicobacter pylori cell wall and urease enzyme.

Targets

Helicobacter pylori cell wall and urease enzyme

Marketed (2)

• standard quadruple therapy · Les Laboratoires des Médicaments Stériles · Infectious Disease
  Standard quadruple therapy combines four antimicrobial agents to treat infections, typically used in tuberculosis or Helicobacter pylori eradication.
• Modified bismuth-containing eradication treatment · Athens Medical Center · Gastroenterology / Infectious Disease
  Bismuth-containing compounds eradicate Helicobacter pylori by disrupting bacterial cell wall integrity and inhibiting urease enzyme activity.